Nuformix plc

LSE (GBp): Nuformix plc (NFX)

Last Price

0.314

Today's Change

-0.001 (0.31%)

Day's Change

0.30 - 0.323

Trading Volume

23,261,271

Overview

Market Cap

6 Million

Shares Outstanding

1 Billion

Avg Volume

54,856,829

Avg Price (50 Days)

0.17

Avg Price (200 Days)

0.11

PE Ratio

0.00

EPS

0.00

Earnings Announcement

03-Dec-2025

Previous Close

0.32

Open

0.32

Day's Range

0.3 - 0.3225

Year Range

0.04 - 0.365

Trading Volume

23,261,271

Price Change Highlight

1 Day Change

-1.59%

5 Day Change

8.77%

1 Month Change

113.79%

3 Month Change

254.29%

6 Month Change

116.78%

Ytd Change

520.00%

1 Year Change

396.00%

3 Year Change

-17.33%

5 Year Change

-90.31%

10 Year Change

-88.19%

Max Change

-88.19%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment